PRPF6
protein-codingpre-mRNA processing factor 6, the group of U5 small nuclear ribonucleoprotein
Gene summary
The protein encoded by this gene appears to be involved in pre-mRNA splicing, possibly acting as a bridging factor between U5 and U4/U6 snRNPs in formation of the spliceosome. The encoded protein also can bind androgen receptor, providing a link between transcriptional activation and splicing. [provided by RefSeq, Jul 2008]
- C20orf14
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~52.0 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AD
Disease ID:MONDO:0013516
Submitter: G2P
Inheritance Pattern: AD
Disease ID:MONDO:0019200
Submitter: Orphanet
Inheritance Pattern: AD
Disease ID:MONDO:0013516
Submitter: PanelApp Australia
Inheritance Pattern: AD
Disease ID:MONDO:0013516
Submitter: Ambry Genetics
Inheritance Pattern: AD
Disease ID:MONDO:0013516
Submitter: Labcorp Genetics (formerly Invitae)
Clinical Genomic Database (CGD)
Manifestation: Ophthalmologic
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to PRPF6 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_012469.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 7 | 217 | 8 | 232 | ||
| missense | 4 | 271 | 11 | 286 | ||
| nonsense | 1 | 7 | 8 | |||
| start loss | 0 | |||||
| frameshift | 14 | 1 | 15 | |||
| splice donor/acceptor (+/-2bp) | 10 | 2 | 12 | |||
| Total | 0 | 5 | 309 | 231 | 8 | 553 |
Highest pathogenic variant AF is 0.000010260662
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_036601.2 | 21 | MANE Select | |
| Ensembl | ENSP00000266079.4 | 21 | MANE Select | |
| Ensembl | ENSP00000525596.1 | 21 | Standard | |
| Ensembl | ENSP00000525596.1 | 21 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Spliceosome - Homo sapiens (human)
- mRNA Processing
- Metabolism of RNA
- mRNA Splicing - Major Pathway
- mRNA Splicing - Minor Pathway
Biological Process
- spliceosomal tri-snRNP complex assembly
- spliceosomal complex assembly
- RNA splicing, via transesterification reactions
- mRNA splicing, via spliceosome
- RNA localization
Molecular Function
- transcription coactivator activity
- RNA binding
- protein binding
- ribonucleoprotein complex binding
- androgen receptor binding
Cellular Component
- nucleus
- nucleoplasm
- spliceosomal complex
- U5 snRNP
- membrane
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000266079
- Coding exons
- 21
- Length
- 51966
- Individuals with no LoFs
- 125712
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 36
- Defined
- 125748
- p
- 0.000143
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 4.85 | 242 | 567 | 0.427 | 0.0000391 | 6160 |
| Missense (PolyPhen) | 28 | 145.19 | 0.19285 | 1559 | ||
| Synonymous | -0.750 | 241 | 227 | 1.06 | 0.0000161 | 1833 |
| Loss of Function | 4.78 | 15 | 52.3 | 0.287 | 0.00000283 | 575 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00013 | 0.00012 | rare |
| Latino/Admixed American | 0.00014 | 0.00014 | rare |
| Ashkenazi Jewish | 0.00020 | 0.00020 | rare |
| East Asian | 0.00022 | 0.00022 | rare |
| Finnish | 0.00019 | 0.00018 | rare |
| European (Non-Finnish) | 0.00012 | 0.00011 | rare |
| South Asian | 0.00016 | 0.00016 | rare |
| Other | 0.00016 | 0.00016 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Involved in pre-mRNA splicing as component of the U4/U6- U5 tri-snRNP complex, one of the building blocks of the spliceosome (PubMed:28781166, PubMed:21549338). Enhances dihydrotestosterone-induced transactivation activity of AR, as well as dexamethasone-induced transactivation activity of NR3C1, but does not affect estrogen-induced transactivation. {ECO:0000269|PubMed:12039962, ECO:0000269|PubMed:21549338, ECO:0000269|PubMed:28781166}.;
Recessive Scores
- pRec
- 0.357
Intolerance Scores
- LoFtool
- 0.461
- RVIS EVS
- -1.38
- RVIS percentile EVS
- 4.39
Essentials
- Essential (CRISPR)
- E
- Essential (CRISPR2)
- E
- Essential (gene trap)
- E
- Indispensability pred.
- E
- Indispensability score
- 0.982
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |